Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB-1, and androgen receptor
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB-1, and androgen receptor
Authors
Keywords
-
Journal
PROSTATE
Volume 73, Issue 12, Pages 1336-1344
Publisher
Wiley
Online
2013-06-15
DOI
10.1002/pros.22681
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gender Influences the Class III and V -Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
- (2012) M. Mariani et al. CLINICAL CANCER RESEARCH
- Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
- (2012) Masaki Shiota et al. JOURNAL OF UROLOGY
- Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
- (2011) M. S. Darshan et al. CANCER RESEARCH
- Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression
- (2011) M. Shiota et al. ENDOCRINE-RELATED CANCER
- Y-Box Binding Protein-1 Mediates Profibrotic Effects of Calcineurin Inhibitors in the Kidney
- (2011) L. Hanssen et al. JOURNAL OF IMMUNOLOGY
- Long-Term Androgen Ablation and Docetaxel Up-Regulate Phosphorylated Akt in Castration Resistant Prostate Cancer
- (2011) Takeo Kosaka et al. JOURNAL OF UROLOGY
- Antioxidant Therapy Alleviates Oxidative Stress by Androgen Deprivation and Prevents Conversion From Androgen Dependent to Castration Resistant Prostate Cancer
- (2011) Masaki Shiota et al. JOURNAL OF UROLOGY
- Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer
- (2011) M. Shiota et al. MOLECULAR CANCER RESEARCH
- Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
- (2011) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
- (2010) M.-L. Zhu et al. CANCER RESEARCH
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Novel therapeutic strategies following docetaxel-based chemotherapy in castration-resistant prostate cancer
- (2010) Naohiro Fujimoto et al. Expert Review of Clinical Pharmacology
- Increased expression of class III β-tubulin in castration-resistant human prostate cancer
- (2009) S Terry et al. BRITISH JOURNAL OF CANCER
- Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
- (2009) Valentina Evdokimova et al. CANCER CELL
- Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer
- (2009) L. Gan et al. CANCER RESEARCH
- Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth
- (2009) M. Shiota et al. CANCER RESEARCH
- Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression
- (2009) M Shiota et al. ONCOGENE
- Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: Implications for PSA surrogacy
- (2009) Kenji Kuroda et al. PROSTATE
- Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer
- (2008) Kim N. Chi et al. JOURNAL OF UROLOGY
- A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate
- (2008) Robert J. Amato et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started